Pharmaceutical

Key to new Cancer drugs discovered in bacterial genomes Achievement is made by the scientists of The Scripps Research Institute (TSRI) Florida campus who had previously discovered LNM E1 compound used to kill prostate cancer. This time they have unlocked the capability of LNM family molecules by “mining” the information stored in bacterial genomes and bringing them even closer to the clinical trials. Present research results suggest that these hidden genes hold the key to developing new, even more, effective cancer-targeting compounds. New Research paper could increase pressure on CRISPR biotechs Recently published paper in a journal has revealed that a “cutting”...